首页 | 本学科首页   官方微博 | 高级检索  
     

三维适形放射治疗鼻咽癌的疗效及局部复发的因素分析
引用本文:Tang YQ,Luo W,He ZC,Sun Y,Lu TX. 三维适形放射治疗鼻咽癌的疗效及局部复发的因素分析[J]. 癌症, 2006, 25(3): 330-334
作者姓名:Tang YQ  Luo W  He ZC  Sun Y  Lu TX
作者单位:华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心放疗科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心放疗科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心放疗科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心放疗科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心放疗科,广东,广州,510060
摘    要:
背景与目的:鼻咽癌常规二维放射治疗的效果不尽人意,三维适形放射治疗可以得到比二维放射治疗更优的剂量分布。本研究探讨鼻咽癌三维适形放射治疗的效果和意义,并探索影响局部复发的剂量学因素。方法:回顾性分析87例进行三维适形放射治疗的初治鼻咽癌患者,并对7例局部区域复发病例进行剂量学分析。结果:全组共有5例原发灶和2例颈部淋巴结复发,3年局部区域控制率为90.2%,T1、T2、T3和T4的局部控制率分别为95.0%、97.0%、80.1%和100%(P=0.340)。剂量学分析显示大多数患者(5/7)为野外或野边缘复发。无进展生存超过12个月的62例患者3~4级晚期反应的发生率为9.7%。87例患者的3年总生存率和3年无进展生存率分别为88.2%和80.3%,Q92分期Ⅰ期、Ⅱ期、Ⅲ期和Ⅳa期的3年生存率分别为100%、100%、84.7%和47.5%(P<0.001)。结论:初治鼻咽癌的三维适形放射治疗可以取得较好的疗效。靶区勾画范围不足,是导致局部复发的原因之一。

关 键 词:鼻咽肿瘤  三维适形放射治疗  疗效  局部复发  剂量学分析
文章编号:1000-467X(2006)03-0330-05
收稿时间:2005-05-27
修稿时间:2005-07-08

Three-dimensional conformal radiotherapy for primary nasopharyngeal carcinoma and analysis of locoregional recurrence
Tang Yi-Qiang,Luo Wei,He Zhi-Chun,Sun Ying,Lu Tai-Xiang. Three-dimensional conformal radiotherapy for primary nasopharyngeal carcinoma and analysis of locoregional recurrence[J]. Chinese journal of cancer, 2006, 25(3): 330-334
Authors:Tang Yi-Qiang  Luo Wei  He Zhi-Chun  Sun Ying  Lu Tai-Xiang
Affiliation:1. State Key Laboratory of Oncology in South China, Guangzhou , Guangdong , 510060, P. R. China; 2. Department of Radiation Oncology , Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P. R. China
Abstract:
BACKGROUND & OBJECTIVE: The efficacy of routine two-dimensional radiotherapy for primary nasopharyngeal carcinoma (NPC) is dissatisfied, while three-dimensional conformal radiotherapy (3-D CRT) can optimize irradiation dose distribution. This study was to explore the efficacy of 3-D CRT on NPC, and investigate dosimetric factors of locoregional failure. METHODS: Records of 87 patients with primary NPC, treated with 3-D CRT between Feb. 2001 and Apr. 2004, were retrospectively reviewed. Dosimetric analysis was performed on the patients with locoregional relapse. RESULTS: Of the 87 patients, 5 (5.7%) had local failure, and 2 (2.3%) had regional failure. The overall 3-year locoregional control rate was 90.2%. The 3-year local control rates for stages T1, T2, T3, and T4 patients were 95.0%, 97.0%, 80.1%, and 100%, respectively. Five cases (71%) were marginal or outside failures of the irradiation fields. The occurrence rate of grade 3-4 late complications of the 62 patients progress-freely survived over 12 months was 9.7%. The 3-year overall survival rate and progress-freely survival rate were 88.2% and 80.3%, respectively. The 3-year survival rates were significantly higher in the patients at stages I, II, and III ('92 Fuzhou staging) than in the patients at stage IVa (100%, 100%, 84.7% vs. 47.5%, P<0.001). CONCLUSIONS: Increased locoregional control rate and reduced occurrence of grade 3-4 late complications of primary NPC could be achieved by 3-D CRT through careful delineation of target volumes and design of irradiation fields. Missing of target volumes is a reason of local relapse.
Keywords:Nasopharyngeal neoplasms  Three-dimensional conformal radiotherapy  Treatment effectiveness  Locoregional reccurrence  Dosimetric analysis
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号